| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fiona Chan, David Berhanu, Sara Samadzadeh, Anna Francis, Nasrin Asgari, Friedemann Paul, M Isabel Leite, Ruth Geraldes, Jacqueline Palac. Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD. Multiple sclerosis (Houndmills, Basingstoke, England). 2025-03-15. PMID:40088045. |
smoking and vascular risk factors (vrfs) are reported to have adverse effects in multiple sclerosis but data are limited in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad). |
2025-03-15 |
2025-03-18 |
Not clear |
| Sarah Demortiere, Natacha Stolowy, Marine Perriguey, Clemence Boutiere, Audrey Rico, Frederic Hilezian, Blaise-Roger Ndjomo-Ndjomo, Pierre Durozard, Jan-Patrick Stellmann, Romain Marignier, José Boucraut, Jean Pelletier, Adil Maarouf, Bertrand Audoi. Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Neurology(R) neuroimmunology & neuroinflammation. vol 12. issue 3. 2025-03-14. PMID:40085804. |
a simple, quick, and reproducible procedure for distinguishing multiple sclerosis (ms), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), and neuromyelitis optica spectrum disorder (nmosd) at inaugural optic neuritis (ion) could be highly valuable in guiding early management. |
2025-03-14 |
2025-03-17 |
Not clear |
| Masayuki Tahara, Tomonari Awaya, Keisuke Saito, Hideyuki Sawad. Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes. Frontiers in immunology. vol 16. 2025-03-12. PMID:40070831. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated diseases (mogad), which has been recognized as a distinct entity in patients with neuromyelitis optica spectrum disorders, often presents with acute disseminated encephalomyelitis (adem) symptoms in pediatric patients. |
2025-03-12 |
2025-03-14 |
Not clear |
| Sotaro Mori, Norio Chihara, Yuto Iwaki, Mina Okuda-Arai, Fumio Takano, Kaori Ueda, Mari Sakamoto, Yuko Yamada-Nakanishi, Riki Matsumoto, Makoto Nakamur. Evaluation of Brain and Spinal Cord Lesions and Cerebrospinal Fluid Analysis in Detecting Demyelinating Diseases in Patients with Optic Neuritis. Neuro-ophthalmology (Aeolus Press). vol 49. issue 2. 2025-03-07. PMID:40051714. |
optic neuritis can be an early sign of demyelinating diseases like multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody-associated diseases (mogad). |
2025-03-07 |
2025-03-09 |
Not clear |
| Ningning Wang, Wei Chen, Huijun Wang, Yongjie Yao, Yuxin Li, Haiqing Li, Xueling Liu, Zhuyun Liu, Ahmed Abouzied, Xiaodi Jin, Shengjun Wang, Xue Bai, Jingli Shan, Anning L. MRI-based radiomics for differention of aquaporin 4-immunoglobulin G-positive neuromyelitis optic spectrum disorder and anti myelin oligodendrocyte glycoprotein immunoglobulin G-associated disorder. Multiple sclerosis and related disorders. vol 95. 2025-02-25. PMID:39999591. |
this study was designed to develop and validate a radiomic nomogram for the differential diagnosis of myelin oligodendrocyte glycoprotein antibody-related disease (mogad) and aquaporin-4 immunoglobulin g-positive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2025-02-25 |
2025-02-28 |
Not clear |
| Liliana C Wu, Sonya Bells, Julie Tseng, Sridar Narayanan, Douglas L Arnold, E Ann Yeh, Donald J Mabbot. Associations between fronto-limbic white matter connections and internalizing symptoms in pediatric demyelinating disease. Multiple sclerosis and related disorders. vol 95. 2025-02-23. PMID:39987890. |
children with neuroinflammatory disorders, such as multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein-associated disorder (mogad), have high rates of anxiety and depression. |
2025-02-23 |
2025-02-26 |
Not clear |
| Benjamin Leger, Antoine Gueguen, Augustin Lecler, Marine Boudot de la Motte, Cédric Lamirel, Caroline Bensa, Catherine Vignal, Romain Marignier, Caroline Papeix, Romain Deschamp. Long-Term Outcome and Prognosis of Idiopathic Optic Neuritis: A Cohort Study. European journal of neurology. vol 32. issue 2. 2025-02-20. PMID:39972602. |
patients diagnosed with optic neuritis (on) who did not fulfil the diagnostic criteria for multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmo-sd), tested negative myelin oligodendrocyte glycoprotein immunoglobulin g and for which a systemic disease has been excluded are classified as having idiopathic on (idon). |
2025-02-20 |
2025-02-23 |
Not clear |
| Qianlan Chen, Henri Trang, Patrick Schindler, Frederike Cosima Oertel, Tim Hartung, Darius Mewes, Claudia Chien, Stefan Hetzer, Lina Anderhalten, Michael Sy, Carsten Finke, Tanja Schmitz-Hübsch, Alexander U Brandt, Friedemann Pau. Neurite orientation dispersion and density imaging in myelin oligodendrocyte glycoprotein antibody-associated disease and neuromyelitis optica spectrum disorders. Multiple sclerosis and related disorders. vol 95. 2025-02-16. PMID:39955814. |
neurite orientation dispersion and density imaging in myelin oligodendrocyte glycoprotein antibody-associated disease and neuromyelitis optica spectrum disorders. |
2025-02-16 |
2025-02-23 |
Not clear |
| Qianlan Chen, Henri Trang, Patrick Schindler, Frederike Cosima Oertel, Tim Hartung, Darius Mewes, Claudia Chien, Stefan Hetzer, Lina Anderhalten, Michael Sy, Carsten Finke, Tanja Schmitz-Hübsch, Alexander U Brandt, Friedemann Pau. Neurite orientation dispersion and density imaging in myelin oligodendrocyte glycoprotein antibody-associated disease and neuromyelitis optica spectrum disorders. Multiple sclerosis and related disorders. vol 95. 2025-02-16. PMID:39955814. |
aquaporin-4 antibody positive (aqp4+) neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are two distinct antibody-mediated neuroinflammatory diseases. |
2025-02-16 |
2025-02-23 |
Not clear |
| Rachel C Kenney, Thomas A Flagiello, Anitha D' Cunha, Suhan Alva, Scott N Grossman, Frederike C Oertel, Friedemann Paul, Kurt G Schilling, Laura J Balcer, Steven L Galetta, Lekha Pandi. Advancing Optical Coherence Tomography Diagnostic Capabilities: Machine Learning Approaches to Detect Autoimmune Inflammatory Diseases. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2025-02-06. PMID:39910704. |
in many parts of the world including india, the prevalence of autoimmune inflammatory diseases such as neuromyelitis optica spectrum disorders (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), and multiple sclerosis (ms) is rising. |
2025-02-06 |
2025-02-08 |
Not clear |
| M Johnsson, K Eriksson, I Rosenstein, L Novakova, C Malmeström, J Lycke, S Sandgren, H Zetterberg, K Blennow, K Johansson, M Axelsso. The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use. Multiple sclerosis and related disorders. vol 94. 2025-02-02. PMID:39893752. |
diagnosing neuromyelitis optica spectrum disorder (nmosd) may be challenging owing to overlapping clinical features with multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), particularly in aqp4-igg seronegative nmosd patients. |
2025-02-02 |
2025-02-05 |
Not clear |
| Spencer K Hutto, Julien J Cavanag. Advances in Diagnosis and Management of Atypical Demyelinating Diseases. The Medical clinics of North America. vol 109. issue 2. 2025-02-01. PMID:39893021. |
this article comprehensively reviews atypical cns demyelinating diseases, beginning with the general approach to cns demyelination, continuing with suggestions to facilitate the initial evaluation, and followed by a discussion about specific diseases (neuromyelitis optica, myelin oligodendrocyte glycoprotein antibody disease, acute disseminated encephalomyelitis, iatrogenic cns demyelination, and transverse myelitis). |
2025-02-01 |
2025-02-04 |
Not clear |
| Siva Sakthivel, Shruthi T K, Saji James, RanjithKumar Manokara. Myelin oligodendrocyte glycoprotein antibody-associated disease mimicking neuromyelitis optica spectrum disorder. BMJ case reports. vol 18. issue 1. 2025-01-19. PMID:39828304. |
myelin oligodendrocyte glycoprotein antibody-associated disease mimicking neuromyelitis optica spectrum disorder. |
2025-01-19 |
2025-01-23 |
Not clear |
| Siva Sakthivel, Shruthi T K, Saji James, RanjithKumar Manokara. Myelin oligodendrocyte glycoprotein antibody-associated disease mimicking neuromyelitis optica spectrum disorder. BMJ case reports. vol 18. issue 1. 2025-01-19. PMID:39828304. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and neuromyelitis optica spectrum disorders (nmosd) are two rare autoimmune inflammatory demyelinating diseases involving the central nervous system, which are often seen with combined involvement of the optic nerve and spinal cord. |
2025-01-19 |
2025-01-23 |
Not clear |
| Étienne Bénard-Séguin, Christopher Nielsen, Abdullah Sarhan, Abdullah Al-Ani, Antoine Sylvestre-Bouchard, Derek M Waldner, Lindsey B De Lott, Suresh Subramaniam, Fiona Costell. The Role of Artificial Intelligence in Predicting Optic Neuritis Subtypes From Ocular Fundus Photographs. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 44. issue 4. 2025-01-14. PMID:39808513. |
notably, on associated with multiple sclerosis (ms on) has a good prognosis for recovery irrespective of treatment, whereas on associated with other conditions including neuromyelitis optica spectrum disorders or myelin oligodendrocyte glycoprotein antibody-associated disease is often associated with less favorable outcomes. |
2025-01-14 |
2025-01-17 |
Not clear |
| R S Shaik, V H Ganaraja, A Bhattacharya, Manoj Kumar, L K Nitish, M Bhat, P K Pal, A Mahadevan, M Netravath. Preliminary observations in cortical excitability changes using transcranial magnetic stimulation (TMS), it's correlation with diffusion tensor imaging (DTI) in subjects with neuromyelitis optica spectrum disorder (NMOSD). Acta neurologica Belgica. 2025-01-12. PMID:39800771. |
neuromyelitis optica spectrum disorder (nmosd) is a relapsing central nervous system disease most commonly associated with aquaporin-4 antibodies (aqp4-ab) and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2025-01-12 |
2025-01-16 |
human |
| Sara I Taha, Salwa I Bakr, Nermeen T Fouad, Dina Zamzam, Yasmine A Mohame. Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients. Scientific reports. vol 15. issue 1. 2025-01-09. PMID:39789036. |
clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in egyptian patients. |
2025-01-09 |
2025-01-13 |
Not clear |
| Rahul Kumar, Ethan Waisberg, Joshua Ong, Phani Paladugu, Dylan Amiri, Jeremy Saintyl, Jahnavi Yelamanchi, Robert Nahouraii, Ram Jagadeesan, Alireza Tavakkol. Artificial Intelligence-Based Methodologies for Early Diagnostic Precision and Personalized Therapeutic Strategies in Neuro-Ophthalmic and Neurodegenerative Pathologies. Brain sciences. vol 14. issue 12. 2025-01-08. PMID:39766465. |
these include alzheimer's disease, parkinson's disease, multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. |
2025-01-08 |
2025-01-13 |
Not clear |
| Nadhirah Ahmad Fauzi, Abd Bari Muhd-Syafi, Abdul Hadi Rosli, Wan Muhammad Najib Wan Mahmud Sabri, Aidila Jesmin Jabbar. Bilateral Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Optic Neuritis: A Case Report. Cureus. vol 16. issue 11. 2025-01-01. PMID:39741598. |
in recent years, there has been increased awareness regarding differentiating ms from other demyelinating on phenotypes, namely, neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2025-01-01 |
2025-01-04 |
Not clear |
| Vivien Häußler, Corinna Trebst, Daniel Engels, Hanna Pellkofer, Joachim Havla, Ankelien Duchow, Patrick Schindler, Carolin Schwake, Thivya Pakeerathan, Katinka Fischer, Marius Ringelstein, Gero Lindenblatt, Martin W Hümmert, Daria Tkachenko, Franziska Bütow, Katrin Giglhuber, Martina Flaskamp, Insa Schiffmann, Mirjam Korporal-Kuhnke, Sven Jarius, Eva Dawin, Lisa Revie, Makbule Senel, Mariella Herfurth, Annette Walter, Mosche Pompsch, Ingo Kleiter, Klemens Angstwurm, Matthias Kaste, Matthias Grothe, Jonathan Wickel, Paulus Stefan Rommer, Jörn Peter Sieb, Markus Krämer, Florian Then Bergh, Hayrettin Tumani, Luisa Klotz, Brigitte Wildemann, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Friedemann Paul, Tania Kümpfel, Tim Friede, Achim Berthele, Jan-Patrick Stellman. Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD. Journal of neurology, neurosurgery, and psychiatry. 2024-12-27. PMID:39730197. |
recurrent attacks in neuromyelitis optica spectrum disorders (nmosds) or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) can lead to severe disability. |
2024-12-27 |
2024-12-30 |
Not clear |